Status:
COMPLETED
Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives
Lead Sponsor:
Democritus University of Thrace
Conditions:
Glaucoma
Glaucoma; Drugs
Eligibility:
All Genders
35-90 years
Brief Summary
Primary objective of this study is to study the efficacy of travoprost without preservatives in the treatment of glaucoma patients and to monitor the ocular surface.
Detailed Description
This is a prospective study including patients visiting the outpatient glaucoma clinic of the University General Hospital of Alexandroupolis for their standard evaluation. Study population is already ...
Eligibility Criteria
Inclusion
- Patients with glaucoma treated with travoprost without preservatives.
Exclusion
- Co-administration of another anti-glaucoma preparation with or without preservatives, Sjogren's syndrome, poor eyelid occlusion of any etiology.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05319470
Start Date
March 15 2022
End Date
May 15 2023
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, University Hospital of Alexandroupolis
Alexandroupoli, Evros, Greece, 68100